Inducible adeno-associated virus vectors promote functional angiogenesis in adult organisms via regulated vascular endothelial growth factor expression

Cardiovascular Research

Volumn 83, Issue 4, 2009, Pages 663-671

  Tafuro, Sabrina ^a   Ayuso, Eduard ^b   Zacchigna, Serena ^a   Zentilin, Lorena ^a   Moimas, Silvia ^a   Dore, Franca ^c   Giacca, Mauro ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITY HOSPITAL OF TRIESTE   (Italy)

Author keywords

AAV vectors; Angiogenesis; Gene therapy; VEGF; Vessel maturation

Indexed keywords

DOXYCYCLINE; PARVOVIRUS VECTOR; TRANSACTIVATOR PROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE THERAPY; HINDLIMB; HISTOPATHOLOGY; LIMB ISCHEMIA; MOLECULAR IMAGING; MOUSE; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIBIALIS ANTERIOR MUSCLE;

ANIMALS; DEPENDOVIRUS; DOXYCYCLINE; GENE EXPRESSION; GENETIC VECTORS; HUMANS; ISCHEMIA; MICE; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; RECOMBINANT PROTEINS; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 68949163249     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp152     Document Type: Article

References (39)

1. Coultas L, Chawengsaksophak K, Rossant J. Endothelial cells and VEGF in vascular development. Nature 2005;438:937-945.
2. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005;438:932-936.
3. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9:669-676.
4. Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 2007;8:464-478.
5. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling-in control of vascular function. Nat Rev Mol Cell Biol 2006;7:359-371.
6. Babiak A, Schumm AM, Wangler C, Loukas M, Wu J, Dombrowski S et al. Coordinated activation of VEGFR-1 and VEGFR-2 is a potent arteriogenic stimulus leading to enhancement of regional perfusion. Cardiovasc Res 2004;61:789-795.
7. Rissanen TT, Yla-Herttuala S. Current status of cardiovascular gene therapy. Mol Ther 2007;15:1233-1247.
8. Tsurumi Y, Kearney M, Chen D, Silver M, Takeshita S, Yang J et al. Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene. Circulation 1997;96:II-382-388.
9. Liu Q, Muruve DA. Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther 2003;10:935-940.
10. Gounis MJ, Spiga MG, Graham RM, Wilson A, Haliko S, Lieber BB et al. Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle. Gene Ther 2005;12:762-771.
11. Springer ML, Ozawa CR, Banfi A, Kraft PE, Ip TK, Brazelton TR et al. Localized arteriole formation directly adjacent to the site of VEGF-induced angiogenesis in muscle. Mol Ther 2003;7:441-449.
12. Ozawa CR, Banfi A, Glazer NL, Thurston G, Springer ML, Kraft PE et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 2004;113:516-527.
13. Shimpo M, Ikeda U, Maeda Y, Takahashi M, Miyashita H, Mizukami H et al. AAV-mediated VEGF gene transfer into skeletal muscle stimulates angio-genesis and improves blood flow in a rat hindlimb ischemia model. Cardiovasc Res 2002;53:993-1001.
14. Arsic N, Zentilin L, Zacchigna S, Santoro D, Stanta G, Salvi S et al. Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors. Mol Ther 2003;7:450-459.
15. Ferrarini M, Arsic N, Recchia FA, Zentilin L, Zacchigna S, Xu X et al. Adeno-Associated Virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs. Circ Res 2006;98:954-961.
16. Dvorak HF. Rous-Whipple Award Lecture. How tumors make bad blood vessels and stroma. Am J Pathol 2003;162:1747-1757.
17. Zacchigna S, Tasciotti E, Kusmic C, Arsic N, Sorace O, Marini C et al. In vivo imaging shows abnormal function of vascular endothelial growth factor-induced vasculature. Hum Gene Ther 2007;18:515-524.
18. Lee RJ, Springer ML, Blanco-Bose WE, Shaw R, Ursell PC, Blau HM. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 2000;102:898-901.
19. Greenberg JI, Shields DJ, Barillas SG, Acevedo LM, Murphy E, Huang J et al. A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 2008;456:809-813.
20. Baron U, Bujard H. Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances. Methods Enzymol 2000;327:401-421.
21. Zentilin L, Marcello A, Giacca M. Involvement of cellular double-strand DNA break-binding proteins in processing of recombinant adenoassociated virus (AAV) genome. J Virol 2001;75:12279-12287.
22. Zentilin L, Tafuro S, Zacchigna S, Arsic N, Pattarini L, Sinigaglia M et al. Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels. Blood 2006;107:3546-3554.
23. Zacchigna S, Pattarini L, Zentilin L, Moimas S, Carrer A, Sinigaglia M et al. Bone marrow cells recruited through the neuropilin-1 receptor promote arterial formation at the sites of adult neoangiogenesis. J Clin Invest 2008;118:2062-2075.
24. Stabile E, Burnett MS, Watkins C, Kinnaird T, Bachis A, la Sala A et al. Impaired arteriogenic response to acute hindlimb ischemia in CD4-knockout mice. Circulation 2003;108:205-210.
25. Diez-Roux G, Argilla M, Makarenkova H, Ko K, Lang RA. Macrophages kill capillary cells in G1 phase of the cell cycle during programmed vascular regression. Development 1999;126:2141-2147.
26. Arsic N, Zacchigna S, Zentilin L, Ramirez-Correa G, Pattarini L, Salvi A et al. Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo. Mol Ther 2004;10:844-854.
27. Riu E, Chen ZY, Xu H, He CY, Kay MA. Histone modifications are associated with the persistence or silencing of vector-mediated transgene expression in vivo. Mol Ther 2007;15:1348-1355.
28. Suzuki M, Kasai K, Saeki Y. Plasmid DNA sequences present in conventional herpes simplex virus amplicon vectors cause rapid transgene silencing by forming inactive chromatin. J Virol 2006;80:3293-3300.
29. McGee Sanftner LH, Rendahl KG, Quiroz D, Coyne M, Ladner M, Manning WC et al. Recombinant AAV-mediated delivery of a tet-inducible reporter gene to the rat retina. Mol Ther 2001;3:688-696.
30. Bohl D, Salvetti A, Moullier P, Heard JM. Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector. Blood 1998;92:1512-1517.
31. Rendahl KG, Leff SE, Otten GR, Spratt SK, Bohl D, Van Roey M et al. Regulation of gene expression in vivo following transduction by two separate rAAV vectors. Nat Biotechnol 1998;16:757-761.
32. Yang J, Zhou W, Zhang Y, Zidon T, Ritchie T, Engelhardt JF. Concatamerization of adeno-associated virus circular genomes occurs through intermolecular recombination. J Virol 1999;73:9468-9477.
33. Favre D, Blouin V, Provost N, Spisek R, Porrot F, Bohl D et al. Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus. J Virol 2002;76:11605-11611.
34. Stieger K, Le Meur G, Lasne F, Weber M, Deschamps JY, Nivard D et al. Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors. Mol Ther 2006;13:967-975.
35. Dor Y, Djonov V, Abramovitch R, Itin A, Fishman GI, Carmeliet P et al. Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J 2002;21:1939-1947.
36. Bornstein P. Thrombospondins as matricellular modulators of cell function. J Clin Invest 2001;107:929-934.
37. Foo SS, Turner CJ, Adams S, Compagni A, Aubyn D, Kogata N et al. Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell 2006;124:161-173.
38. Fisher KJ, Jooss K, Alston J, Yang Y, Haecker SE, High K et al. Recombinant adeno-associated virus for muscle directed gene therapy. Nat Med 1997;3:306-312.
39. Vincent-Lacaze N, Snyder RO, Gluzman R, Bohl D, Lagarde C, Danos O. Structure of adeno-associated virus vector DNA following transduction of the skeletal muscle. J Virol 1999;73:1949-1955.